Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07285564

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Centre Henri Becquerel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).

Detailed description

In approximately 20% of cases, surgical margins are considered insufficient. The only tool currently available intraoperatively to assess the quality of surgical resection is the extemporaneous examination. This has a sensitivity of only 10%. The objective is therefore to evaluate the performance of another tool, available intraoperatively, to help surgeons assess the quality of their resection. Currently, micro-PET-CT allows for the evaluation of surgical specimens (CE marking and FDA approval obtained). Its performance in the evaluation of surgical margins remains to be demonstrated. This is the subject of the present study.

Conditions

Interventions

TypeNameDescription
DEVICEmicro PET/CTPET/T of the speciment after surgery

Timeline

Start date
2025-11-07
Primary completion
2026-03-15
Completion
2026-06-15
First posted
2025-12-16
Last updated
2025-12-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07285564. Inclusion in this directory is not an endorsement.